AMYTAL SODIUM CAP 60MG DIN 00015148
Health Canada record
| Active ingredient(s) | AMOBARBITAL SODIUM 60 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | CONTROLLED DRUGS (CDSA IV) |
| Class | Human |
| ATC | N05CA02 AMOBARBITAL |
| Original market date | 31-Dec-1951 |
| Current status date | 05-Mar-2004 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pharmascience Inc. — licence 100241, currently licensed, last inspection rating C (2025-03-20).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing AMOBARBITAL SODIUM
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00015350 | AMYTAL SODIUM 500MG | ELI LILLY CANADA INC | Powder For Solution | AMOBARBITAL SODIUM 500 MG | Cancelled Post Market |
| 00015156 | AMYTAL SODIUM PULVULE 222 0.2GM | PHARMASCIENCE INC | Capsule | AMOBARBITAL SODIUM 200 MG | Cancelled Post Market |
International API supply for AMOBARBITAL SODIUM
1 active FDA Drug Master Files.
Request a quote for AMYTAL SODIUM CAP 60MG